Contact us to get started

Hope begins here.

If you're an HR or benefits professional seeking cancer resources for your employees, or a consultant looking to provide best-in-class cancer support for your clients, share a few details below. We’ll reach out to help your company get started.

If you’re an employee looking for your AccessHope benefit, call 800.423.3232 and select Option 1.

How we make a difference

Keeping members close to home. Lending needed support to local oncologists. It all makes a world of difference.

AccessHope’s Impact

AccessHope takes great pride in making a real and tangible difference for members as they deal with cancer. Our data demonstrate a measurable impact across the board.

Influence: 93%

AccessHope is making recommendations for improvements in 93% of cancer cases in which we are asked to contribute. In 2 out of 3 cases, at least one recommendation to change treatment was implemented. Our specialists and their expertise are nudging a majority of members and their physicians toward more suitable treatments.

 

 

9M+ Lives

The number of lives AccessHope stands ready to help continues to grow. We now partner with more than 700 employers, including more than 70 Fortune 500 companies, to cover 9 million people.

Net Promoter Score: 79

AccessHope’s Cancer Support Team's Net Promoter Score is 79. Compared to a healthcare industry average score of 5-15, AccessHope is excelling at providing insightful, helpful information to members, their families and caregivers.

dollar_icon
 

Cancer Care Is Expensive

Cancer generally is in the top three diagnostic categories for employers, driving a significant portion of medical spending. A mismatch in the treatment plan may lead to suboptimal care that increases costs without improving outcomes. AccessHope helps advise on optimal treatment plans from the start, ensuring money is well spent.

Hear from an AccessHope oncology nurse about what it's like to contact the Cancer Support Team.

AccessHope Launches New Service to Help More Cancer Patients Enroll in Clinical Trials

Read the Press Release